SCHEMBL21217769

SCHEMBL21217769

Cc1cc(Nc2nnc(-c3ccc(OCCCNC(=O)C(C)C)cc3)[nH]2)ccc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41
▸ TBK1 Q9UHD2 1/20 0.41
▸ BRD4 O60885 2/20 0.35
▸ PTGES O14684 1/20 0.34
▸ CA12 O43570 5/20 0.34
▸ CA1 P00915 5/20 0.34
▸ CA2 P00918 5/20 0.34
▸ CA4 P22748 5/20 0.34
▸ CA9 Q16790 5/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ XIAP P98170 1/20 0.33
▸ SLC2A1 P11166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24610309 0.88 IKBKE (0.39) IKBKEAURKBTBK1BRD4PTGES
SCHEMBL24094286 0.85 IKBKE (0.36) IKBKEAURKBTBK1PTGESCA12
SCHEMBL21217865 0.82 MEN1 (0.43) IKBKEAURKBTBK1
SCHEMBL22966756 0.79 MEN1 (0.44) —
SCHEMBL10271069 0.77 CARM1 (0.46) BRD4CA12CA1CA2CA4
SCHEMBL4974356 0.74 ALDH1A1 (0.44) BRD4CA12CA1CA2CA4
SCHEMBL24610300 0.72 JAK2 (0.34) SMN1; SMN2
SCHEMBL24610274 0.72 HTR1D (0.32) HSD17B10CYP1A2TP53
SCHEMBL24094128 0.70 PLG (0.34) HSD17B10CYP1A2TP53
SCHEMBL21217755 0.69 MEN1 (0.44) AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019145729-A1 HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE REDX PHARMA PLC (GB) 2019-08-01 — — WO disclosed
Send feedback